14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock News

$3.36
+0.195 (+6.16%)
At Close: May 27, 2022
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on United Therapeutics (UTHR – Research Report),
Komisi Pemberantasan Korupsi (KPK), Kamis menahan dua tersangka kasus suap terkait pemberian fasilitas atau perizinan keluar di Lapas Klas I Sukamiskin, ...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hologic (HOLX) and Vertex Pharmaceuticals (VRTX) with
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hologic (HOLX
Oppenheimer analyst Hartaj Singh maintained a Buy rating on United Therapeutics (UTHR) today and set a price target of $155.00. The company's shares
Oppenheimer analyst Hartaj Singh maintained a Buy rating on United Therapeutics (UTHR – Research Report) today and set a price
In a report released today, Hartaj Singh from Oppenheimer assigned a Buy rating to Gilead Sciences (GILD), with a price target of $80.00. The company's
In a report released today, Hartaj Singh from Oppenheimer assigned a Buy rating to Gilead Sciences (GILD – Research Report),
The vehicles are being used to transport critical equipment, medical supplies and meals to team workers and their families living in the UAE
Apr 29, 2020 (The Expresswire) -- The report outlines the competitive framework of the “DHA Algae Oil for Food and Beverage Market” industry detailing the...
Wedbush analyst Liana Moussatos maintained a Buy rating on Eiger Biopharmaceuticals (EIGR) today and set a price target of $33.00. The company's shares
Wedbush analyst Liana Moussatos maintained a Buy rating on Eiger Biopharmaceuticals (EIGR – Research Report) today and set a price
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Lexicon Pharmaceuticals (LXRX), with a price target of $9.00. The
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report),
Catabasis Pharmaceuticals to Report First Quarter 2020 Financial Results on Tuesday, May 12th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE